Squeeze Fires Bearish As Price Drops Into The Lower Quarter

Eli Lilly has broken down with the squeeze firing into bearish momentum. Price is pressing toward the floor of its range and the structure confirms sellers are in control with limited bullish resistance showing up anywhere in the signal suite.

Price is at 1011.55 after a -5.2% retrace with just 0.9% bounce at 0.2x expansion, confirming a breakdown regime. Price percentile sits at 23.2% near the floor of the 1109.21 to 982.04 range. The stock has lost nearly 100 points from the highs and the recovery attempt has been minimal.

Bias is strong bear at 66.7% with a 19:38 signal count out of 112. EMAs read 3:7, candles 3:11, and Ichimoku 5:9. Counter-trend signals lean decisively bearish at 5:9 with engulfing at 0:2. Pattern totals favor bears 3:0 and harami prints 3:0 on the bull side, showing indecision candles are forming but not translating into reversals. Spread strength is 33.3% in the strong zone confirming directional conviction behind the move.

The squeeze has fired with momentum bearish but starting to point upward. Bandwidth is at 4.92%. Squeeze momentum is contracting downward at 403.2%. This is worth noting carefully. The squeeze has already released its energy and momentum is beginning to curl. Contraction rather than expansion in squeeze momentum after a firing event can signal the selling thrust is losing steam.

Volume is quiet at -0.84 Z on just 264 contracts and 267.05K in dollar terms. Direction reads neutral with decelerating momentum at -1.46. Bull and bear Z scores are close at -0.49 and -0.53. OBV at -2.65 shows strong outflow with normal divergence. No whale activity detected.

The OBV reading at -2.65 is heavy. That level of persistent outflow confirms institutional distribution has been happening for some time. This is not a sudden selloff but a sustained exit. The quiet volume during the breakdown suggests orderly selling rather than panic, which often means more downside remains as sellers work through positions methodically.

Scenario 1 (55%) — Continued decline toward the 982 range low. The 19:38 signal count, fired bearish squeeze, OBV at -2.65, and breakdown structure all point lower. A volume pickup near the 982-1000 zone would mark potential capitulation. The engulfing 0:2 count shows bears are overwhelming attempted rallies.

Scenario 2 (45%) — Stabilization and relief bounce from the 1000-1010 area. Squeeze momentum is already contracting and curling upward, which could signal the initial thrust is fading. The 3:0 harami count shows hesitation candles are appearing. If OBV outflow decelerates and volume Z picks up on a green bar, a snapback toward the 1050-1060 zone is possible.

Watch for OBV to reverse from the -2.65 extreme, squeeze momentum to complete its curl upward, and volume to arrive on a reversal candle. The 982 floor is the line in the sand. A break below opens up significantly more downside while a hold could form a double bottom setup.

Risk is high on both sides. Shorting into a 23.2% price percentile carries mean reversion risk while buying into a strong bear breakdown with -2.65 OBV outflow is catching a falling knife. Wait for confirmation before committing. The squeeze momentum curl is the earliest signal to watch for a potential shift.

More analysis on my profile.

LLY, Eli Lilly, Lilly, pharma, healthcare, squeeze, breakdown, volume, equities